Pulmonary and cardiovascular late effects of ionizing radiation alone or combined with chemotherapy;Les effets tardifs pulmonaires et cardiaques induits par les radiations ionisantes seules ou associees a la chimiotherapie

Cancer/Radiotherapie

Volumn 1, Issue 6, 1997, Pages 735-743

  Girinsky, T ^a   Cosset, J M ^b  

^a INSTITUT GUSTAVE ROUSSY   (France)

^b INSTITUT CURIE   (France)

Author keywords

Chest irradiation; Heart; Late complications; LENT SOMA; Lung

Indexed keywords

CYTOKINE; PLATELET DERIVED GROWTH FACTOR B; TRANSFORMING GROWTH FACTOR BETA;

CANCER RADIOTHERAPY; CORONARY ARTERY DISEASE; HEART MUSCLE CONDUCTION DISTURBANCE; HUMAN; IONIZING RADIATION; LUNG FIBROSIS; MORTALITY; PERICARDITIS; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; REVIEW; RISK FACTOR; VALVULAR HEART DISEASE;

EID: 0031417567     PISSN: 12783218     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1278-3218(97)82950-2     Document Type: Article

References (51)

1. Applefield MM, Wiernik PH. Cardiac disease after radiation therapy for Hodgkin's disease: analysis of 48 patients. Am J Cardiol 1983;51:1679-81
2. Billingham ME. Endomyocardial changes in anthracycline-treated patients with and without irradiation. Front Radiat Ther Oncol 1979;13:67-81
3. Boivin JF, Hutchinson GB, Lubin JH, Mauch P. Coronary artery disease mortality in patients treated for Hodgkin's disease. Cancer 1992;69:1241-7
4. Boothman DA, Lee IW, Sahijdak WM. Isolation of an X-ray responsive element in the promoter region fo tissue-type plasminogen activator: potential uses of X-ray responsive elements for gene therapy. Radiat Res 1994;138:S68-S71
5. Breur K, Cohen P, Schweisguthe O, Hart AMM. Irradiation of the lungs as an adjuvant therapy in the treatment of osteosar-coma of the limbs. Eur J Cancer 1978;14:464-71
6. Brosius FC, Waller BF, Roberts WC. Radiation heart disease. Analysis of 16 young (aged 15 to 33 years) necropsy patients who received over 3500 rads to the heart. Am J Med 1981;70:519-29
7. Carmel RJ, Kaplan HS. Mantle irradiation in Hodgkin's disease. Cancer 1976;37:2813-5
8. Catane R, Schwade JG, Turrisi AT, Webber BL, Muggia FM. Pulmonary toxicity after radiation and bleomycin: a review. Int J Radiat Oncol Biol Phys 1979;5:1513-8
9. Chan PYM, Kagan AR, Byfield JE, Rao AA, Gilbert HA, Nussbaum H. Pulmonary complications of combined chemotherapy and radiotherapy in lung cancer. Front Radiat Ther Oncol 1979;13:136-44
10. Corn BW, Track BJ, Goodman RL. Irradiation-related ischemic heart disease. J Clin Oncol 1990;8:741-50
11. Cosset JM, Henry-Amar M, Girinsky T, Malaise E, Dupouy N, Dutreix J. Late toxicity of radiotherapy in Hodgkin's disease: the role of fraction size. Acta Oncol 1988;27:123-30
12. Cosset JM, Henry-Amar M, Pellae-Cosset B, Carde P, Girinski T, Tubiana M et al. Pericarditis and myocardial infarction after Hodgkin's disease therapy. Int J Radiat Oncol Biol Phys 1991;21:447-9
13. Cosset JM, Henry-Amar M, Dietrich PY, Socié G, Girinsky T, Hayat et al. Les tumeurs solides secondaires après irradiation pour maladie de Hodgkin: l'expérience de l'institut Gustave-Roussy. Bull Cancer 1992;79:387-8
14. Curtis RE, Rowlings PA, Deeg J, Shriner DA, Socié G, Travis LB et al. Solid cancers after bone marrow transplantation. N Engl J Med 1997;336:897-904
15. Fajardo LF, Stewart JR. Pathogenesis of radiation-induced myocardial fibrosis. Lab Invest 1973;29:244-57
16. Fraser RG, Paré JAP. Diagnosis of Diseases of the Chest. Philadelphia, London, Toronto: Saunders Company, 1970
17. Gillette EL, McChesney SL, Hoopes PJ. Isoeffect curves for radiation-induced cardiomyopathy in the dog. Int J Radiat Oncol Biol Phys 1985;11:2091-7
18. Glanzman C, Huguenin P, Lutolf UM, Maire R, Jenni R, Gumppenberg V. Cardiac lesions after mediastinal irradiation for Hodgkin's disease. Radiother Oncol 1994;30:43-54
19. Gross NJ. Pulmonary effects of radiation therapy. Ann Int Med 1977;86:81-92
20. Gustavsson A, Eskilsson J, Landberg T, Svahn-Tapper G, White T, Wollmer P et al. Late cardiac effects after mantle field radiotherapy in patients with Hodgkin's disease. Ann Oncol 1990;1:355-63
21. Hallahan DE, Virudachalam S, Sherman ML, Huberman E, Kufe DW. Tumor necrosis factor gene expression is mediated by protein kinase C following activation by ionizing radiation. Cancer Res 1991;51:4565-9
22. Hancock SL, Donaldson SS. Radiation-related cardiac disease: risks after treatment of Hodgkin's disease during childhood and adolescence. Proceedings of Second International Conference on the Long-Term Complications Treatment of Children and Adolescents for Cancer, Buffalo NY, June 12-14, 1992
23. Hancock SL, Hoppe RT. Long-term complications of treatment and causes of mortality after Hodgkin's disease. Sem Radiat Oncol 1996;6(3):225-42
24. Henry-Amar M. Seconds cancers après traitement pour maladie de Hodgkin : l'expérience de l'International Database on Hodgkin's disease. Bull Cancer 1992;79:389-91
25. Henry-Amar M, Hayat M, Meerwaldt J, Burgers M, Carde P, Somers R et al. Causes of death after therapy for Hodgkin's disease entered on EORTC protocols. Int J Radiat Oncol Biol Phys 1990;19:1155-7
26. Horning SJ, Adhikari A, Rizk N, Hoppe R, Olshen R. Effect of treatment for Hodgkin's disease on pulmonary function: results of a prospective study. J Clin Oncol 1994;2:297-305
27. Joensuu H. Acute myocardial infarction after heart irradiation in young patients with Hodgkin's disease. Chest 1989;95:388-90
28. Kreuser ED, Voller H, Behles C, Schroder K, Uhrig A, Besserer A et al. Evaluation of late cardiotoxicity with pulsed doppler echocardiography in patients treated for Hodgkin's disease. Br J Haematol 1993;84:615-22
29. Libshitz HI, Shuman LS. Radiation induced pulmonary changes: CT findings. J Comput Assist Tomogr 1984;8:15-9
30. Lindahl J, Strender LE, Larsson LE, Unsgaard A. Electrocardiographic changes after radiation therapy for carcinoma of the breast. Acta Radiol Oncol 1983;22:433-40
31. McChesney SL, Gillette EL, Powers BE. Radiation-induced cardiomyopathy in the dog. Radiat Res 1988;113:120-32
32. Morgan GM, Freeman AP, McLean RG, GarvieBH, Giles RW. Late cardiac, thyroid, and pulmonary sequellae of mantle radiotherapy for Hodgkin's disease. Int J Radiat Oncol Biol Phys 1985;11:1925-31
33. Newton KA, Spittle MF. An analysis of 40 cases treated by total thoracic irradiation. Clin Radiol 1969;20:19-22
34. O'Driscoll BR, Hasleton PS, Taylor PM, Poulter LW, Gattamaneni HR, Woodcock AA. Active lung fibrosis up to 17 years after chemotherapy with carmustine (BCNU) in childhood. N Engl J Med 1990;323:378-82
35. Perez CA, Stanley K, Rubin P, Kramer S, Brady L, Perez-Tamayo R et al. A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Cancer 1980;45:2744-53
36. Pierga JY, Maunoury C, Valette H, Socié G, Girinsky T, Tchernia G et al. Follow-up thallium-201 scintigraphy after mantle field radiotherapy for hodgkin's disease. Int J Radiat Oncol Biol Phys 1993;25:871-6
37. Rab GT, Ivans JC, Child DS, Copps RE, Pritchard DJ. Elective whole lung irradiation in the treatment of osteogenic carcinoma. Cancer 1976;38:939-42
38. Roach III M, Gandara DR, Yuo HS, Swift PS, Kroll S, Shrieve DC et al. Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol 1995;16:2606-12
39. Rubin P, Finkelstein J, Shapiro D. Molecular biology mechanisms in the radiation induction of pulmonary injury syndromes: interrelationship between the alveolar macrophage and the septal fibroblast. Int J Radiat Oncol Biol Phys 1992;24:93-101
40. Rubin P, Johnston CJ, Williams JP, McDonald S, Finkelstein JN. A perpetual cascade of cytokines postirradiation leads to pulmonary fibrosis. Int J Radiat Oncol Biol Phys 1995;33:99-109
41. Rutqvist LE, Lax I, Fornander T, Johansson H. Cardiovascular mortality in a randomized trial of adjuvant radiation therapy vs surgery alone in primary breast cancer. Int J Radiat Oncol Biol Phys 1992;22:887-96
42. Santoro A, Bonnadonna G, Valagussa P, Zucali R, Viviani S, Villani F et al. Long-term results of combined chemotherapy-radiotherapy approach in Hodgkin's disease: superiority of ABVD plus radiotherapy versus MOPP-radiotherapy. J Clin Oncol 1987;5:27-37
43. Shapiro SJ, Shapiro SD, Mill WB, Campbell EJ. Prospective study of long-term manifestations of mantle irradiation. Int J Radiat Oncol Biol Phys 1990;19:707-14
44. Simpson JR, Francis ME, Perez-Tamayo R, Marks RD, Rao DV. Palliative radiotherapy for inoperable carcinoma of the lung: final report of a RTOG multi-institutional trial. Int J Radiat Oncol Biol Phys 1985;11:751-8
45. Smith LM, Mendenhall NP, Cicale MJ, Block ER, Carter RL, Million RR. Results of a prospective study evaluating the effects of mantle irradiation on pulmonary function. Int J Radiat Oncol Biol Phys 1989;16:79-84
46. Stewart JR, Cohn KE, Fajardo LF, Hancock EW, Kaplan HS. Radiation-induced heart disease. Radiology 1967;89:302-10
47. Thames HD, Hendry JH. Fractionation in radiotherapy. In: Response of Tissues to Fractionated Irradiation: Effect of Repair. Taylorand Francis, 1987:53-99
48. Thornton SC, Bennet S, Robbins JM, Foulcher E, Morgan GW, Penny R et al. Radiation lung injury is associated with induction of macrophage derived fibroblast growth factors (à paraître)
49. Von der Maase H, Overgaard J, Vaeth M. Effect of cancer chemotherapeutic drugs on radiation-induced lung damage in mice. Radiother Oncol 1986;5:245-57
50. Weichselbaum RR, Hallahan D, Fuks Z, Kufe D. Radiation induction of immediate early gene effectors of the radiation-stress response. Int J Radiat Oncol Biol Phys 1994;31:229-34
51. Wohl ME, Griscom NT, Traggis DG, Jaffe N. Effects of therapeutic irradiation delivered in early childhood upon subsequent lung function. Pediatrics 1975;55:507-14